68

APT Medical IncSHG 688617 Stock Report

Last reporting period 30 Sep, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

4.572

Middle

Exchange

XSHG - Shanghai Stock Exchange

688617.SS Stock Analysis

68

Uncovered

APT Medical Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

4.572

Dividend yield

0.42 %

Shares outstanding

66.67 B

APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 1,511 full-time employees. The company went IPO on 2021-01-07. The firm's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The firm's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The firm is also engaged in related original equipment manufacturer (OEM) business. The firm distributes its products within domestic market and to overseas markets.

View Section: Eyestock Rating